{
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "document": {
    "pdf_name": "Hsiao_et_al.__2023_",
    "source_pdf": "data/clinical_files/Hsiao et al. (2023).pdf",
    "total_pages": 11,
    "total_blocks": 147,
    "total_characters": 24458
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 2,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "The Flublok Quadrivalent influenza vaccine (RIV4, Sanofi) is manufactured without chicken eggs, resulting in a recombinant hemagglutinin protein that is genetically identical to that in the selected strain.",
      "relevance_explanation": "This quote directly states that Flublok's hemagglutinin protein is genetically identical to that in the selected strain, supporting the claim that Flublok ensures an identical antigenic match with the WHO- and FDA-selected flu strains."
    },
    {
      "id": 2,
      "quote": "In traditional quadrivalent standard dose inactivated influenza vaccines (SD-IIV4), chicken eggs are used to manufacture the vaccine strain. The recombinant formulation is not susceptible to antigenic drift during manufacturing.",
      "relevance_explanation": "This quote explains that unlike egg-based vaccines, the recombinant (Flublok) formulation avoids antigenic drift during manufacturing, supporting the claim that it maintains an identical antigenic match to the selected strains."
    }
  ],
  "model_used": "gpt-4.1"
}